Stock listing
PRE Stock Price, News, Filings & Events — Prenetics Global Limited
Selected listing: PRE · NASDAQ · USD · US
This page tracks Prenetics Global Limited's PRE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRE:NASDAQ. PRE:NASDAQ is the stock-level entry point for investors researching Prenetics Global Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prenetics Global Limited, trading under the ticker PRE, is a public company listed in the American market. The company has a market capitalization of approximately $315.36 million. Prenetics focuses on providing innovative genetic and diagnostic testing solutions.
- Ticker
- PRE:NASDAQ
- Asset type
- Stock
- Market cap
- $441.6M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
Prenetics Global Limited PRE:NASDAQ stock context
This page tracks Prenetics Global Limited's PRE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRE:NASDAQ. PRE:NASDAQ is the stock-level entry point for investors researching Prenetics Global Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Prenetics Global Limited, trading under the ticker PRE, is a public company listed in the American market. The company has a market capitalization of approximately $315.36 million. Prenetics focuses on providing innovative genetic and diagnostic testing solutions.
Latest news from Prenetics Global Limited
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
August 26, 2026
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Mo...
August 18, 2026
Prenetics Global : 2Q26 Letter to Shareholders
August 18, 2026
Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Confer...
August 7, 2026
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized...
June 10, 2026
Prenetics Global Limited earnings calls
Prenetics Global Limited (PRE) Q2 2026 Earnings Call
August 18, 2026 · Replay with transcript and chapters
Prenetics Global Limited (PRE) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Prenetics Global Limited (PRE) Q4 2025 Earnings Call
February 18, 2026 · Replay with transcript and chapters
Prenetics Global Limited (PRE) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Research Prenetics Global Limited
Prenetics Global Limited investor report
Review AI stock analysis and investor report context for PRE:NASDAQ.
Prenetics Global Limited company profile
View the public company page for Prenetics Global Limited on 6ix.
Prenetics Global Limited news
Read company news and market updates connected to Prenetics Global Limited.
Prenetics Global Limited investor events
Find investor webinars, events, and replay context for Prenetics Global Limited.